If youre not seeing those numbers, you wont see the gradual effects of metformin. It is common for people to stop taking metformin due to the drugs potential digestive side effects
The company will aim to rely more on GLP-1 drugs that have been specifically approved for obesity like Wegovy, she said
Symptoms include tiredness, weakness, shortness of breath with mild exertion, and cold hands and feet
van Bloemendaal L, Ten Kulve JS, la Fleur SE, Ijzerman RG, Diamant M
If you have a history of certain cancers or conditions, discuss alternative strategies with your provider
Here, we have used glucagon-like peptide-1 (GLP-1) as a model peptide therapeutic for treating obesity-linked type 2 diabetes, a common chronic disease